Zenta Tsuchihashi
Senior Director, Translational Patient Safety, Clinical Safety & Pharmacovigilance Daiichi Sankyo
Seminars
Monday 23rd February 2026
Exploring Predictive Biomarkers for ADC Drug-Induced Pulmonary Toxicities: The Enhertu Experience
2:00 pm
- Overviewing biomarkers for ADC drug induced pulmonary toxicities
- Bridging non-clinical toxicology findings and clinical translational safety research
- Case study: Assessing ILD concerns in HER2-targeted ADCs to explore how biomarkers in blood helping refine prediction and how can we monitor and treat ADC toxicities
